Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma.

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Journal of Laboratory and Clinical Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.5555/URI:PII:0022214374900250PMID 4808653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of volatile mercaptans in whole blood.

  1973cited by this paper
• Mercaptans and dimethyl sulfide in the breath of patients with cirrhosis of the liver. Effect of feeding methionine.

  1970cited by this paper
• Formation of artifactual ammonia in blood by action of alkali. Its significance for the measurement of blood ammonia.

  1961cited by this paper
• Enzymic methylation of foreign sulfhydryl compounds

  1961cited by this paper
• Methionine toxicity in liver disease and its prevention by chlortetracycline.

  1956cited by this paper
• A relation between non-esterified fatty acids in plasma and the metabolism of glucose.

  1956cited by this paper
• Methyl mercaptan in relation to foetor hepaticus.

  1955cited by this paper
• Studies on protein synthesis in vitro. IV. Concerning the apparent uptake of methionine by particulate preparation from liver.

  1953cited by this paper
• On the Effect and Toxicity of Dimethyl Sulfide, Dimethyl Disulfide and Methyl Mercaptan.

  1943cited by this paper
• Apparatus for the micro-determination of certain volatile substances: The blood ammonia, with observations on normal human blood.

  1935cited by this paper

• Gut microbial metabolites of amino acids in liver diseases

  2025cites this paper
• Chronic Liver Disease: An Updated Review for Healthcare Professionals

  2024cites this paper
• Natural gas odorants: A scoping review of health effects

  2023influential citation
• Recommendations and Guidance on Nutritional Supplementation in the Liver Transplant Setting

  2021cites this paper
• Hepatic Encephalopathy

  2020cites this paper
• RIFM fragrance ingredient safety assessment, dimethyl sulfide, CAS Registry Number 75-18-3.

  2020cites this paper
• RIFM fragrance ingredient safety assessment, methyl mercaptan, CAS Registry Number 74-93-1.

  2020cites this paper
• Preliminary results of toxicity studies in rats following low-dose and short-term exposure to methyl mercaptan

  2019cites this paper
• Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis

  2019cites this paper
• Methyl Mercaptan

  2019cites this paper
• Chapter Ammonia

  2019cites this paper
• Concentration-time extrapolation of short-term inhalation exposure levels: dimethyl sulfide, a case study using a chemical-specific toxic load exponent

  2018influential citation
• Dietary Interventions in Liver Cirrhosis

  2018cites this paper
• 14 – Neurologic Consequences of Liver Disease

  2018cites this paper
• Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study

  2017cites this paper
• Hepatic encephalopathy

  2016cites this paper
• Peritoneal Albumin Dialysis as a Novel Approach for Liver Support: Study in a Porcine Model of Acute Hepatic Failure.

  2016cites this paper
• Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited

  2015cites this paper
• The why and wherefore of hepatic encephalopathy

  2015cites this paper
• Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view

  2014cites this paper
• Hepatic Encephalopathy: From the Pathogenesis to the New Treatments

  2014cites this paper
• Characteristics and Nursing Activities of Severe Trauma Patients Regarding the Main Damaged Body Parts

  2013cites this paper
• The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus

  2013influential citation
• Hepatobiliary quiz-7 (2013).

  2013cites this paper
• Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.

  2013cites this paper
• Hepatobiliary quiz-7 (2013).

  2013cites this paper
• HEP-12-0633 . R 3-Marked The Nutritional Management of Hepatic Encephalopathy in Patients with Cirrhosis : ISHEN Consensus

  2013cites this paper
• Portal-Systemic Encephalopathy in Emergency Treatment of Cirrhosis and Bleeding Esophageal Varices

  2012cites this paper
• Theories of the pathogenesis of hepatic encephalopathy.

  2012cites this paper
• Hepatic Encephalopathy

  2012cites this paper
• Laser spectroscopy on volatile sulfur compounds: possibilities for breath analysis

  2011cites this paper
• Improving Survival in Patients with Decompensated Cirrhosis

  2011influential citation
• Management of Hepatic Encephalopathy

  2011cites this paper
• Towards application of a human liver cell line for use in the AMC bioartificial liver

  2011cites this paper
• [Portosystemic shunt in the treatment of portal hypertension].

  2010cites this paper
• Treatment Guidelines for Hepatic Encephalopathy

  2010cites this paper
• Assessment of cerebral vascular resistance in cirrhotic patients with hepatic encephalopathy using transcranial color doppler ultrasonography.

  2010cites this paper
• Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

  2010cites this paper
• Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.

  2010cites this paper
• Hepatic encephalopathy: the role of inflammation, ammonia andaquaporin expression in the pathogenesis of cerebral oedema

  2010cites this paper
• The Cat with Neurological Manifestations of Systemic Disease

  2009cites this paper
• Early diagnosis of viral hepatitis and its sequelae Radiological and laparoscopic techniques*

  2009cites this paper
• Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy

  2009cites this paper
• Treatment of feline infectious peritonitis

  2009cites this paper
• Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study

  2009cites this paper
• Mechanism and Treatment of Sulfide-Induced Coma: A Rat Model

  2008influential citation
• Pathophysiology of hepatic encephalopathy: The concept of synergism

  2008cites this paper
• Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients.

  2008cites this paper
• Clinical course and prognosis of one hundred and two patients with hepatic coma 1958 through 1975

  2007cites this paper
• Ammonia causes decreased brain monoamines in fathead minnows (Pimephales promelas).

  2007cites this paper
• Environmental aspects of VOCs evolved in the early stages of human decomposition.

  2007cites this paper
• Visual Evoked Potentials in Encephalopathy Induced by Galactosamine, Ammonia, Dimethyldisulfide, and Octanoic Acid

  2007cites this paper
• Management of hepatic encephalopathy in patients with cirrhosis.

  2007cites this paper
• Hepatic Encephalopathy and Artificial Liver Support Systems

  2006cites this paper
• Management of Hepatic Encephalopathy: Focus on Antibiotic Therapy

  2006cites this paper
• High-protein high-calorie diet for hepatic encephalopathy

  2006cites this paper
• Soy protein diet prevents hypermethioninemia caused by portacaval shunt in rats.

  2006cites this paper
• A Rational Approach to Understand and Manage Hepatic Encephalopathy ( HE / PSE ) in Chronic End-Stage Liver Disease ( Cirrhosis )

  2005influential citation
• Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.

  2005cites this paper
• Ethanethiol [MAK Value Documentation, 2005]

  2005cites this paper
• Fatality due to inhalation of dimethyl sulfide in a confined space: A case report and animal experiments

  2005influential citation
• A study of volatile organic compounds evolved from the decaying human body.

  2005cites this paper
• Treatment of hepatic encephalopathy - systematic Cochrane reviews of randomised clinical trials

  2005cites this paper
• Infection, inflammation and hepatic encephalopathy, synergism redefined.

  2004cites this paper
• A Methodfor Serum Octanoatein HepaticCirrhosisand Hepatic Encephalopathy

  2004cites this paper
• Increased oro-cecal transit time in grade I or II hepatic encephalopathy.

  2004cites this paper
• Toxicological profile for ammonia

  2004cites this paper
• Toxicological profile for ammonia

  2004cites this paper
• Probiotics can treat hepatic encephalopathy.

  2003cites this paper
• Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices

  2003cites this paper
• [Hepatic encephalopathy].

  2003cites this paper
• Pathogenesis of hepatic encephalopathy

  2003cites this paper
• Neurobiology of ammonia.

  2002cites this paper
• Gastric or Rectal Instillation of Short-Chain Fatty Acids Stimulates Epithelial Cell Proliferation of Small and Large Intestine in Rats

  2002cites this paper
• Pathophysiology of Hepatic Encephalopathy: A New Look at Ammonia

  2002cites this paper
• substances in the work environment. Cincinnati, OH: American Conference of Governmental Industrial

  2002cites this paper
• Neurologic complications of critical illness: part I. Altered states of consciousness and metabolic encephalopathies.

  2002cites this paper
• Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible.

  2001cites this paper
• Exercise training in patients with chronic liver disease

  2001cites this paper
• Intrahepatic amino acid and glucose metabolism in a D‐galactosamine–induced rat liver failure model

  2001cites this paper
• Gas chromatography double focusing sector-field ICP-MS as an innovative tool for bad breath research

  2001cites this paper
• Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible.

  2001cites this paper
• 49 – Portal Hypertension and Portacaval Shunt*

  2001cites this paper
• Hepatic encephalopathy

  2001cites this paper
• Pruritus can be soothing in acute viral hepatitis

  2001cites this paper
• Complications of cirrhosis III. Hepatic encephalopathy.

  2000cites this paper
• Hepatic Encephalopathy in Liver Cirrhosis

  2000cites this paper
• A novel stable reproducible model of hepatic failure in canines.

  2000cites this paper
• Is inhaled ammonia neurotoxic

  2000cites this paper
• A review of bioartificial liver development from an artificial organ engineering perspective

  2000cites this paper
• Amino acid metabolism in liver disease.

  1999cites this paper
• Diode laser absorption sensors for gas-dynamic and combustion flows.

  1998cites this paper
• Production and oxidation of short-chain fatty acids in the human colon: implications for antibiotic-associated diarrhea, ulcerative colitis, colonic cancer, and hepatic encephalopathy.

  1998cites this paper
• Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial.

  1998cites this paper
• Acid/base transporters in human duodenal enterocytes.

  1998cites this paper
• Novel strategies for liver support in acute liver failure.

  1997cites this paper
• Treatment of hepatic encephalopathy.

  1997cites this paper
• Portal systemic encephalopathy.

  1997cites this paper
• A clinical hepatologist's predictions about non-absorbed carbohydrates for the early twenty-first century.

  1997cites this paper
• Characteristics of an Albumin Dialysate Hemodiafiltration System for the Clearance of Unconjugated Bilirubin

  1997cites this paper